Supporting Drug Prevention Week

Supporting Drug Prevention Week

By Todd W. Mandel, MD, Bizzell US

National Prevention Week is a Substance Abuse and Mental Health Services Administration (SAMHSA) led national public education campaign highlighting the work of communities and organizations dedicated to raising awareness about substance misuse prevention and positive mental health. Observed May 7–13, this week-long endeavor encourages preventative initiatives and tactics designed to increase positive mental health outcomes.

This collaborative effort helps to strengthen prevention efforts and create a culture of health and wellness, bringing together individuals, organizations, and communities across the country. Please visit the Prevention Week homepage to register and join SAMHSA in honoring of the work of their partners in prevention and celebrating stories of success.

There are numerous dangers of substance use disorders (SUDs) that can affect both an individual’s physical and mental health. SUDs can cause changes in brain chemistry that can facilitate the development of mood disorders, anxiety, and depression. SUDs contribute to potentially fatal overdoses, and other issues such as heart disease, liver and kidney damage, and respiratory issues. Additionally, SUDs can disrupt personal relationships, cause financial problems, and even lead to legal issues.

According to the CDC figures cited by the Drug Enforcement Agency (DEA), 107,375 people in the United States died of drug overdoses and drug poisonings in the 12-month period ending in January 2022 [1]United States Drug Enforcement Administration. (2022, April 29). Fentanyl Awareness. Retrieved May 9, 2023, from https://www.dea.gov/fentanylawareness. A staggering 67 percent of those deaths involved synthetic opioids, like fentanyl, with some of these deaths attributed to fentanyl mixed with other illicit drugs like cocaine, methamphetamine, and heroin. This illicit mixture leaves many users unaware they were taking fentanyl, further contributing to overdoses. Only two milligrams of fentanyl can be a potentially lethal dose, particularly for someone who does not have an opioid tolerance. Recent data from the DEA indicates that Fentanyl is involved in more deaths of Americans under 50 than any cause of death, including heart disease, cancer, homicide, suicide, and accident-related deaths [1]United States Drug Enforcement Administration. (2022, April 29). Fentanyl Awareness. Retrieved May 9, 2023, from https://www.dea.gov/fentanylawareness.

While the focus of National Prevention Week is providing an educational forum to encourage people to not start using substances, for those who are already facing challenges with SUDs, effective treatments are available. There are also other strategies and resources for overdose prevention. Bizzell US, through its work with The National Institute on Drug Abuse Clinical Trials Network, produced online educational resources on topics for screening, fentanyl overdose prevention, and treatment for methamphetamine use disorder:

Prevention efforts such as education and awareness campaigns, early intervention programs, and easy access to treatment and support are essential to reduce drug use and its harmful consequences. By working together as a community to prioritize drug use prevention, we can help individuals and families avoid the devastating effects of drug addiction, promoting a safer and healthier future for everyone.

 

References

[1] United States Drug Enforcement Administration. (2022, April 29). Fentanyl Awareness. Retrieved May 9, 2023, from https://www.dea.gov/fentanylawareness.

 

happy people stacking hands outdoor

Bizzell Awarded Four SAMHSA IDIQ Domains

Bizzell Awarded Four SAMHSA IDIQ Domains

Bizzell US (Bizzell), a global strategy, consulting, and technology firm, is excited to continue its successful partnership with the Substance Abuse and Mental Health Services Administration (SAMHSA). Bizzell has been awarded four domains as a prime contractor on SAMHSA’s Indefinite Delivery Indefinite Quantity (IDIQ) contract through 2027. The IDIQs help SAMHSA achieve its goal of reducing the impact of substance abuse and mental illness on America’s communities.

Through this award, Bizzell is eligible to compete for new contracts under the following domains:

  • Domain I: Feasibility, Pilot, and Evaluation Projects
  • Domain II: Statistical Projects
  • Domain V: Technical Assistance and Training Projects
  • Domain VI: Planning, Implementation, and Report Support Projects (8a and HUBZone)

Since Bizzell’s inception, the firm has worked with SAMHSA and other agencies within the Department of Health and Human Services to accelerate behavioral health advancements and improve services and resources for communities within the United States and across the globe. Bizzell has a full range of capabilities that can support SAMHSA’s mission, and includes program and project management, data analytics, evaluation and learning, and technical assistance and training.

Bizzell has conducted a wide range of feasibility studies, evaluation projects, and didactic learning seminars to strengthen health system interventions and training, foster data-informed decisions, and improve program outcomes and impact. Specifically, we’ve partnered with SAMHSA to provide direct technical assistance and support services to opioid treatment programs nationwide. Additionally, we’ve delivered in-person and web-based provider trainings in the areas of prevention treatment and recovery, substance use disorder and maternal and infant health, effective uses of medication assisted treatment, and improving cultural competence in substance abuse treatment.

“As a company, Bizzell is passionate about developing innovative solutions that lead to positive health outcomes,” says Anton Bizzell, M.D., President and CEO of Bizzell. “We are energized to support SAMSHA’s critical work to advance the nation’s behavioral health—especially now as more people struggle with mental health and substance use concerns and the demand for effective and accessible behavioral health services is growing.”

About Bizzell

Established in 2010, Bizzell US is U.S. Small Business Administration (SBA) HUBZone certified strategy, consulting, and technology firm with a mission to improve lives and accelerate change. Bizzell US develops innovative solutions to some of the most critical issues of our time such as health care services equity, global health, workforce innovation and other urgent needs facing the world. Under the leadership and vision of founder, Anton C. Bizzell, MD, the company has grown into a thriving firm headquartered in New Carrollton, Maryland with staff and offices in various regions around the country including California, Colorado, Oklahoma, and Georgia, and globally in Africa, Asia, and Central America. Learn more about how we develop data-driven, research-informed, innovative solutions to complex-real-world challenges. Learn more at BizzellUS.com.

The Bizzell Group Contact
Chad Brown DM, Chief Administrative Officer
301-459-0100 | cbrown@thebizzellgroup.com

3 Xanax Addiction Signs to Lookout For

3 Xanax Addiction Signs to Lookout For

Nearly 52 million Americans 18 and older are living with a mental illness and/or substance use disorder.  In the midst of the COVID-19 pandemic, reports of people suffering from panic disorders and anxiety are increasing. A common medication for treating panic disorders and anxiety is a prescription drug called Xanax. While Xanax can help relieve anxiety and panic symptoms, it is highly addictive. It is important that individuals taking Xanax become aware of the signs of an addiction to Xanax, which can include withdrawing from relationships and preoccupation with your Xanax use.  As individuals become preoccupied with maintaining a steady supply of Xanax, financial troubles and concerning behaviors may increase. In a recent WebMD Connect to Care article on signs of Xanax addiction, Dr. Anton C. Bizzell, CEO of The Bizzell Group and a substance abuse expert, highlighted some additional telltale signs: “Maintaining a supply of the drug on hand, mixing with alcohol or other drugs, and developing dangerous behaviors to obtain the prescription, including stealing or getting it from the streets.”

Recognizing the signs of an addiction is an important step towards getting help to treat an addiction—for yourself or others you love.

READ MORE: 3 Xanax Addiction Signs to Lookout For

Why Overdose Awareness Matters More Than Ever

Why Overdose Awareness Matters More Than Ever

International Overdose Awareness Day, August 31st, began in Australia 20 years ago to raise awareness of overdoses, reduce the stigma of drug-related deaths, and remind us of the grief felt by the families and friends of those who have died due to substance use disorders (SUD). Today, International Overdose Awareness Day is recognized in more than 40 countries.

Isolation individuals have experienced during the COVID-19 pandemic has exacerbated mental health and SUD challenges, and reduced access to supportive communities and behavioral health care. Substance use and overdose deaths have increased during the pandemic.

The Substance Abuse and Mental Health Services Administration (SAMHSA) and others have developed approaches, tips, and guidance for managing your mental health during this time, as well as links for locating treatment for substance use disorders. Anton C. Bizzell, MD, President/CEO of The Bizzell Group, has dedicated his career to improving access to quality substance abuse, mental health, and medical treatment and prevention services, and writes about timely behavioral health solutions in his monthly Psychology Today column, Mind Your Health. You can make a difference too, by accessing these resources and promoting behavioral health in your community.

Read more: Why Overdose Awareness Matters More Than Ever